Oxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trial
OXB announces that its proprietary lentiviral vector manufacturing technology will be used in Boehringer Ingelheim’s newly initiated LENTICLAIR ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Diginomica6h
Why the UK’s AI ambitions could stall without a focus on data streaming
The UK government’s AI Opportunities Action Plan promises billions in investment to position Britain as a leader in ...
Apple is bringing Visual Intelligence to the iPhone 15 Pro
That suggested that the feature could technically work with the iPhone 15 Pro, which also has an Action Button, and now Apple is confirming that Visual Intelligence will indeed come to that phone and ...
Goldman says these 9 discounted stocks are part of an elite group at the forefront of boosting their sales with AI
The AI trade isn't about Nvidia anymore, according to Goldman Sachs. Instead, invest in companies with AI-enabled revenues.
Microsoft22h
Microsoft’s Majorana 1 chip carves new path for quantum computing
Microsoft today introduced Majorana 1, the world’s first quantum chip powered by a new Topological Core architecture that it expects will realize quantum computers capable of solving meaningful, ...